Patterns of relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy followed by surgery and radiotherapy

Journal of Cancer Research and Therapeutics

Volumn 3, Issue 2, 2007, Pages 75-80

  Yadav, B S ^a   Sharma, S C ^a   Singh, R ^a   Singh, G ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Locally advanced breast cancer; Locoregional recurrence; Neoadjuvant chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADULT; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; MULTIPLE CYCLE TREATMENT; POSTMENOPAUSE; PREMENOPAUSE; RADIATION DOSE; REVIEW; TREATMENT RESPONSE;

EID: 34548667938     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.34683     Document Type: Review

References (23)

1. Skipper HE. Adjuvant chemotherapy. Cancer 1978;41:936-40.
2. Schwartz GF, Birchansky CA, Komarnicky LT, Mansfield CM, Cantor RI, Biermann WA, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 1994;73:362-9.
3. Buchholz TA, Tucker SL, Masullo L, Kuerer HM, Erwin J, Salas J, et al. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 2002;20:17-23.
4. Lenert JT, Vlastos G, Mirza NQ, Winchester DJ, Binkley SM, Ames FC, et al. Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients. Ann Surg Oncol 1999;6:762-7.
5. van der Hage JA, van de Velde CT, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001;19:4224-37.
6. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on outcome of women with operable breast cancer. J Clin Oncol 1998;16:2672-85.
7. Cance WG, Carey LA, Calvo BF, Sartor C, Sawyer L, Moore DT, et al. Long-term outcome of neoadjuvant chemotherapy for locally advanced breast carcinoma: Effective clinical down staging allows breast preservation and predicts outstanding local control and survival. Ann Surg 2002;236:295-303.
8. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, et al. Breast conservation after neoadjuvant chemotherapy: The MD Anderson Cancer Center experience. J Clin Oncol 2004;22:2303-12.
9. Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 1999;230:72-8.
10. de Matteis A, Nuzzo F, D Aiuto G, Labonia V, Landi G, Rossi E, et al. Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast: A single-center, phase II study. Cancer 2002;94:895-901.
11. Ribiero GG, Magee B, Swindell R, Harris M, Banerjee SS. The Christie Hospital breast conservation trial: An update at 8 years from inception. Clin Oncol (R Coll Radiol) 1993;5:278-83.
12. Haagensen CD, Stout AP. Carcinoma of the breast, criteria of inoperability. Ann Surg 1943;118:1032-40.
13. Mirza NQ, Vlastos G, Meric F, Buchholz TA, Esnaola N, Singletary SE, et al. Predictors of locoregional recurrence among patients with early- stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 2002;9:256-65.
14. Fisher B, Redmond C, Poissin R, Margolese R, Wolmark N, Wickerham L, et al. Eight-year results of a randomised clinical trial comparing total mastectomy and lumpectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1989;320:822-8.
15. Fowble BL, Solin LJ, Schult DJ, Goodman RL. Ten- year results of conservative surgery and irradiation for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 1991;21:269-77.
16. Mauriac L, MacGrogan G, Avril A, Durand M, Floquet A, Debled M, et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: Aunicentre randomised trial with a 124-month median follow-up. Ann Oncol 1999;10:47-52.
17. Rouzier R, Evan JM, Carton M, Falcou MC, Vincent-Salomon A, Fourquet A, et al. Primary chemotherapy for operable breast cancer: Incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. J Clin Oncol 2001;19:3828-35.
18. Bonadonna G, Vallagussa P, Brambilla C, Ferrari L, Moliterni A, Terenziani M, et al. Primary chemotherapy in operable breast cancer: Eight-year experience at Milan Cancer Institute. J Clin Oncol 1998;16:93-100.
19. Newman LA, Buzdar AU, Singletary SE, Kuerer HM, Buchholz T, Ames FC, et al. A prospective trial of preoperative chemotherapy in resectable breast cancer: Predictors of breast-conservation therapy feasibility. Ann Surg Oncol 2002;9:228-34.
20. Vlastos G, Mirza NQ, Lenert JT, Hunt KK, Ames FC, Feig BW, et al. The feasibility of minimally invasive surgery for stage IIA, IIB and IIIA breast carcinoma patients after tumor down staging with induction chemotherapy. Cancer 2000;88:1417-24.
21. Singletary SE, McNeese MD, Hortobagyi GN. Feasibility of breast conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 1992;69:2849-52.
22. Touboul E, Lefranc JP, Blondon J, Buffat L, Deniaud E, Belkacémi Y, et al. Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer. Radiother Oncol 1997;42:219-29.
23. Parmar V, Krishnamurthy A, Hawaldar R, Nadkarni MS, Sarin R, Chinoy R, et al. Breast conservation treatment in women with locally advanced breast cancer - Experience from a single centre. Int J Surg 2006;4:106-14.